The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RO6889450 in Healthy Volunteers
PHASE1CompletedINTERVENTIONAL
Enrollment
164
Participants
Timeline
Start Date
March 21, 2016
Primary Completion Date
April 14, 2017
Study Completion Date
April 14, 2017
Conditions
Healthy Volunteer
Interventions
DRUG
Placebo
DRUG
RO6889450
Trial Locations (1)
9471 GP
PRA Health Sciences Early Development Services, Zuidlaren
All Listed Sponsors
lead
Hoffmann-La Roche
INDUSTRY
NCT02699372 - The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RO6889450 in Healthy Volunteers | Biotech Hunter | Biotech Hunter